Inventor
DEMONT EMMANUEL HUBERT
GB22 patents
⚠️ This page may combine multiple inventors who share the name “DEMONT EMMANUEL HUBERT”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GLAXOSMITHKLINE IP NO 2 LTD
11 patentsUS10583112B2Mar 10, 2020
Benzo[b]furans as bromodomain inhibitors
GLAXOSMITHKLINE IP NO 2 LTD2 citations71
US10370356B2Aug 6, 2019
Pyridinone dicarboxamide for use as bromodomain inhibitors
GLAXOSMITHKLINE IP NO 2 LTD6 citations71
US10428026B2Oct 1, 2019
Pyridinone dicarboxamide for use as bromodomain inhibitors
GLAXOSMITHKLINE IP NO 2 LTD2 citations70
US10927080B2Feb 23, 2021
Pyridinone dicarboxamide for use as bromodomain inhibitors
GLAXOSMITHKLINE IP NO 2 LTD0 citations59
US10966961B2Apr 6, 2021
Pyrazole derivatives as bromodomain inhibitors
GLAXOSMITHKLINE IP NO 2 LTD1 citations58
US11319307B2May 3, 2022
2,3-dihydrobenzohurans as bromodomain inhibitors
GLAXOSMITHKLINE IP NO 2 LTD0 citations49
US11273146B2Mar 15, 2022
Benzofuran derivatives and their use as bromodomain inhibitors
GLAXOSMITHKLINE IP NO 2 LTD0 citations49
US10934272B2Mar 2, 2021
Pyridyl derivatives as bromodomain inhibitors
GLAXOSMITHKLINE IP NO 2 LTD0 citations49
US10849897B2Dec 1, 2020
Pyridyl derivatives as bromodomain inhibitors
GLAXOSMITHKLINE IP NO 2 LTD0 citations39
US10844015B2Nov 24, 2020
Pyridine dicarboxamide derivatives as bromodomain inhibitors
GLAXOSMITHKLINE IP NO 2 LTD0 citations39
US10471050B2Nov 12, 2019
2-OXO-1,2-dihydropyridine-3,5-dicarboxamide compounds as bromodomain inhibitors
GLAXOSMITHKLINE IP NO 2 LTD0 citations39
DEMONT EMMANUEL HUBERT
5 patentsUS8580957B2Nov 12, 2013
Thetrahydroquinolines derivatives as bromodomain inhibitors
DEMONT EMMANUEL HUBERT29 citations91
US9067936B2Jun 30, 2015
4-(8-methoxy-1-((1-methoxypropan-2-yl)-2-(tetrahydro-2H-pyran-4-yl)-1 H-imidazo[4,5-C]quinolin-7-yl)-3,5-dimethylisoxazole and its use as bromodomain inhibitor
DEMONT EMMANUEL HUBERT18 citations90
US8697725B2Apr 15, 2014
Tetrahydroquinoline derivatives and their pharmaceutical use
DEMONT EMMANUEL HUBERT19 citations79
US8222245B2Jul 17, 2012
Oxadiazole derivatives active on sphingosine-1-phosphate (S1P)
DEMONT EMMANUEL HUBERT1 citations50
US8846709B2Sep 30, 2014
7-(3,5-dimethyl-4-isoxazolyl)-8-(methyloxy)-1H-imidazo[4,5-C]quinoline derivatives
DEMONT EMMANUEL HUBERT0 citations39
AMANS DOMINIQUE
3 patentsUS9315487B2Apr 19, 2016
Tetrahydroquinoline derivatives useful as bromodomain inhibitors
AMANS DOMINIQUE16 citations82
US8993554B2Mar 31, 2015
Tetrahydroquinoline derivatives useful as bromodomain inhibitors
AMANS DOMINIQUE17 citations82
US9029395B2May 12, 2015
Tetrahydroquinoline derivatives useful as bromodomain inhibitors
AMANS DOMINIQUE17 citations81
GLAXOSMITHKLINE LLC
3 patentsUS9416130B2Aug 16, 2016
4-(8-methoxy-1-((1-methoxypropan-2-yl)-2-(tetrahydro-2H-pyran-4-yl)-1 H-imidazo[4,5-C]quinolin-7-yl)-3,5-dimethylisoxazole and its use as bromodomain inhibitor
GLAXOSMITHKLINE LLC1 citations61
US9861627B2Jan 9, 2018
4-(8-methoxy-1-((1-methoxypropan-2-yl)-2-(tetrahydro-2H-pyran-4-yl)-1 H-imidazo[4,5-C]quinolin-7-yl)-3,5-dimethylisoxazole and its use as bromodomain inhibitor
GLAXOSMITHKLINE LLC0 citations51
US9610284B2Apr 4, 2017
4-(8-methoxy-1-((1-methoxypropan-2-yl)-2-(tetrahydro-2H-pyran-4-yl)-1H-imidazo[4,5-c]quinolin-7-yl)-3,5-dimethylisoxazole and its use as bromodomain inhibitor
GLAXOSMITHKLINE LLC0 citations51